Results 121 to 130 of about 2,077 (188)

Prevalence of urinary tract infections in women with vulvovaginal atrophy and the impact of vaginal prasterone on the rate of urinary tract infections. [PDF]

Menopause
Rubin R, Sanaee M, Yee A, Moyneur E, Dea K, Dury AY.   +5 more
europepmc   +1 more source

Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study. [PDF]

Drugs Context, 2020
Rodríguez SPG.
europepmc   +1 more source

Effect of Vaginal Laser and Topical Therapies on Vulvovaginal Atrophy Symptoms in Breast Cancer Patients: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Lőczi LL, Vleskó G, Éliás M, Turan C, Kajtár P, Tóth R, Sipos M, Nagy R, Hegyi P, Ács N, Várbíró S, Keszthelyi M.   +11 more
europepmc   +1 more source

Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies. [PDF]

Drugs Context, 2020
Salcedo FL, Blanco ZE.
europepmc   +1 more source

Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial. [PDF]

Breast Cancer Res Treat
Faltinová M, Vehmanen L, Lyytinen H, Savolainen-Peltonen H, Virtanen A, Haanpää M, Hämäläinen E, Tiitinen A, Mattson J.   +8 more
europepmc   +1 more source

Reply to Broomfield et al. Comment on "Jankovic et al. Understanding the Benefits of CO₂ Laser Treatment for Vulvovaginal Atrophy. <i>Medicina</i> 2024, <i>60</i>, 1059". [PDF]

Medicina (Kaunas)
Jankovic S, Rovcanin M, Tomic A, Jurisic A, Milovanovic Z, Zamurovic M.   +5 more
europepmc   +1 more source

Assessment of the Efficacy and Safety of a Dual-Wavelength Diode Laser System for the Treatment of Vulvovaginal Atrophy in Women Without a History of Breast Cancer and in Patients with a History of Breast Cancer. [PDF]

J Clin Med
Perrini G, Actis S, Giorgi M, Accomasso F, Minella C, Fava C, Bisconte G, De Rosa G, Ferrero A, Bounous VE.   +9 more
europepmc   +1 more source

Should I stay for local hormone therapy or should I go for radiofrequency to treat vulvovaginal atrophy? A patient preference trial. [PDF]

Menopause
Dell'Utri CM, Manzoni E, Bonfanti I, Marrocco F, Barbara G, Pifarotti P, Chiaffarino F.   +6 more
europepmc   +1 more source

Real‑world performance and safety of vaginal ovules in reducing the vaginal symptoms associated with vulvovaginal atrophy and postmenopausal sexual dysfunction. [PDF]

Biomed Rep
Iliescu DG, Petrita R, Teodorescu C, Olaru RA, Alexa AA, Petre I.   +5 more
europepmc   +1 more source

Study of Vulvovaginal Atrophy and Genitourinary Syndrome of Menopause and Its Impact on the Quality of Life of Postmenopausal Women in Central India. [PDF]

Cureus
Ulhe SC, Acharya N, Vats A, Singh A.
europepmc   +1 more source